RecruitingPhase 4NCT05863416

Dexmedetomidine in Non-intubated VATS

Adjunctive Dexmedetomidine Infusion in Non-intubated Video-assisted Thoracoscopic Surgery


Sponsor

Tri-Service General Hospital

Enrollment

144 participants

Start Date

Apr 23, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This prospective study aims to evaluate the effectiveness of intraoperative DEX for postoperative analgesia and recovery after non-intubated VATS. In addition, the investigators observe the impact of DEX on anesthetic requirements, hemodynamic parameters, and adverse events during non-intubated VATS.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Inclusion Criteria1

  • American Society of Anesthesiologists (ASA) score of I-III patients receiving video-assisted thoracoscopic surgery

Exclusion Criteria7

  • Age \< 18 or \> 80 years
  • ASA classifications \> III
  • Pregnancy
  • Known allergies to any drugs used in the study
  • Emergency surgery
  • Patient refusal
  • Chronic pain history

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGDexmedetomidine infusion

Intraoperative dexmedetomidine infusion


Locations(1)

Tri-Service General Hospital

Taipei, Taiwan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05863416


Related Trials